PLoS ONE (Jan 2021)

LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples.

  • Elizabeth C Stahl,
  • Allan R Gopez,
  • Connor A Tsuchida,
  • Vinson B Fan,
  • Erica A Moehle,
  • Lea B Witkowsky,
  • Jennifer R Hamilton,
  • Enrique Lin-Shiao,
  • Matthew McElroy,
  • Shana L McDevitt,
  • Alison Ciling,
  • C Kimberly Tsui,
  • Kathleen Pestal,
  • Holly K Gildea,
  • Amanda Keller,
  • Iman A Sylvain,
  • Clara Williams,
  • Ariana Hirsh,
  • Alexander J Ehrenberg,
  • Rose Kantor,
  • Matthew Metzger,
  • Kara L Nelson,
  • Fyodor D Urnov,
  • Bradley R Ringeisen,
  • Petros Giannikopoulos,
  • Jennifer A Doudna,
  • IGI Testing Consortium

DOI
https://doi.org/10.1371/journal.pone.0258263
Journal volume & issue
Vol. 16, no. 11
p. e0258263

Abstract

Read online

Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2-3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.